MedicarePartD.guide

A non-government resource built from CMS public data

July 2025 Medicare Drug List Updates: Sixty-two (62) medications added to the 2025 Medicare Part D Drug plan formularies.

Monthly Formulary changes · published Aug 1, 2025

The July 2025 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and the drug finder Drug Finder.

The July formulary updates include the addition of 91 new National Drug Codes (NDCs), representing 62 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the July 2025 Formulary updates include seventeen (17) newly-introduced brand-name drugs

The July drug data updates include thirty-one (31) new brand-name drugs, seventeen (17) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • CTEXLI®,
  • EULEXIN®,
  • FEMLYV®,
  • GOMEKLI®,
  • LUTRATE DEPOT®,
  • ONAPGO®,
  • OPIPZA®,
  • OTULFI®,
  • PYZCHIVA [YESINTEK]®,
  • RALDESY®,
  • ROMVIMZA®,
  • VANRAFIA®,
  • VENXXIVA®,
  • VIMKUNYA®,
  • VYKAT XR®,
  • XROMI®, and
  • YESINTEK®.

The July 2025 Formulary updates include seven (7) newly-added generic drugs

The July Medicare Part D drug data also includes thirty-one (31) new generic medications, seven (7) of which are newly-introduced generic drugs. These drugs include:
  • ABIRTEGA [ZYTIGA®],
  • AURANOFIN [Ridaura®],
  • MERCAPTOPURINE [PURIXAN®],
  • NIMODIPINE [Nymalize®],
  • RIVAROXABAN [Xarelto®],
  • TICAGRELOR [BRILINTA®], and
  • UMECLIDINIUM-VILANTEROL [ANORO ELLIPTA®].
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. In most cases, your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more on this site


Summary of July 2025 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 91 new July 2025 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form1
New Delivery Form and Strength1
New Drug26
New Drug and Strength27
New Drug, Delivery Form and Strength7
New Manufacturer2
New Manufacturer and Delivery Form1
New Manufacturer and Packaging1
New Manufacturer and Strength15
New Manufacturer, Delivery Form and Strength2
New Packaging1
New Strength7
Grand Total91

The following chart details the 91 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.
NDC Drug Name Number of
PDP Formularies*
Number of
MAPD Formularies*
Notes
82249001112ABIRTEGA 250 MG TABLET [ZYTIGA]35323New Drug
61314039164ADALIMUMAB-ADAZ(CF) 10MG/0.1ML SYRINGE [Hyrimoz]316New Strength
00378661393AMNESTEEM 30 MG CAPSULE [ZENATANE]34257New Strength
73352009306AURANOFIN 3 MG CAPSULE [Ridaura]237New Drug
68180094702BETAMETHASONE DP AUG 0.05% OINTMENT [Diprolene]40340New Manufacturer and Delivery Form
29033021501BUTALBITAL-ASPIRIN-CAFFEINE CAPSULE [Fiorinal]990New Drug
15054330401BYLVAY 1,200 MCG CAPSULE216New Drug, Delivery Form and Strength
15054330101BYLVAY 200 MCG PELLET DSP CP216New Drug, Delivery Form and Strength
15054330201BYLVAY 400 MCG CAPSULE217New Drug, Delivery Form and Strength
15054330301BYLVAY 600 MCG PELLET DSP CP216New Drug, Delivery Form and Strength
58151007401CARDURA 1 MG TABLET03New Manufacturer and Strength
68180039507CELECOXIB 50 MG CAPSULE [Celebrex]39343New Manufacturer and Strength
66758007138CILOXAN 0.3% OINTMENT895New Drug
25021011502CLINDAMYCIN PH 300 MG/2 ML VIAL [Cleocin]40327New Strength
25021011504CLINDAMYCIN PH 600 MG/4 ML VIAL [Cleocin]40317New Strength
79378031090CTEXLI 250 MG TABLET112New Drug
73515012330CYCLOSET 0.8 MG TABLET1060New Drug
60505463003CYCLOSPORINE MODIFIED 25 MG CAPSULE [Neoral]40344New Manufacturer and Strength
80005016108E.E.S. 400 MG TABLET587New Drug
00093766356ERLOTINIB HCL 100 MG TABLET [Tarceva]40344New Manufacturer and Strength
00093766456ERLOTINIB HCL 150 MG TABLET [Tarceva]40344New Manufacturer and Strength
80725014318EULEXIN 125 MG CAPSULE40344New Drug
72495060184FEMLYV 1 MG-0.02 MG ODT TABLET RAPDIS318New Drug
16729034210FINGOLIMOD 0.5 MG CAPSULE [Gilenya]30338New Drug
65862030612FLUOXETINE 20 MG/5 ML SOLUTION [Prozac]40344New Delivery Form and Strength
00832167211FLUVOXAMINE MALEATE 100 MG TABLET [Luvox]40344New Manufacturer and Strength
82448013042GOMEKLI 1 MG CAPSULE40344New Drug, Delivery Form and Strength
82448013484GOMEKLI 1 MG TABLET FOR SUSPENSION40344New Drug, Delivery Form and Strength
82448026084GOMEKLI 2 MG CAPSULE40344New Drug, Delivery Form and Strength
81952011606HEPARIN SOD 20,000 UNIT/ML VIAL39321New Manufacturer and Strength
00121193030LACTULOSE 20 GM PACKET [Kristalose]016New Manufacturer and Strength
68180084813LEVONOR-E ESTRAD 0.1-0.02-0.01 TBDSPK 3MO [LoSeasonique]29234New Drug
80725042012LOVAZA 1 GM CAPSULE [Triklo]01New Drug
83831013401LUTRATE DEPOT 22.5 MG VIAL387New Drug
82667060005MAXIDEX 0.1% EYE DROPS W/EYE DROPPER013New Drug
00054458249MERCAPTOPURINE 20 MG/ML ORAL SUSPENSION [PURIXAN]40342New Drug
72336009530METFORMIN HCL 750 MG TABLET070New Strength
75907005330METHYLPHENIDATE ER(LA) 60MG CPBP 50-50 [Ritalin LA]371New Manufacturer and Strength
58657073956METRONIDAZOLE 125 MG TABLET218New Manufacturer and Strength
00054023763MORPHINE SULF 10 MG/5 ML SOLUTION [MSIR]30315New Manufacturer, Delivery Form and Strength
00054023863MORPHINE SULF 20 MG/5 ML SOLUTION [MSIR]30316New Manufacturer, Delivery Form and Strength
82580001002NEFFY 1 MG/0.1 ML NASAL SPRAY08New Strength
82667050003NEVANAC 0.1% EYE DROPS W/EYE DROPPER112New Drug
31722003947NIMODIPINE 60 MG/20 ML SOLUTION [Nymalize]320New Drug
00002771711OMVOH 300 MG DOSE - 2 PEN INJECTORS06New Manufacturer and Strength
00002772211OMVOH 300 MG DOSE - 2 SYRINGES06New Manufacturer and Strength
27505000605ONAPGO 98 MG/20 ML CARTRIDGE055New Drug
15370040330OPIPZA 10 MG FILM35262New Drug and Strength
15370040130OPIPZA 2 MG FILM35262New Drug and Strength
15370040230OPIPZA 5 MG FILM35262New Drug and Strength
65219082401OTULFI 45 MG/0.5 ML SYRINGE01New Drug and Strength
65219082626OTULFI 90 MG/ML SYRINGE01New Drug and Strength
73780000210OXYCODONE HCL 10 MG TABLET [Roxybond]38New Manufacturer and Strength
73780000310OXYCODONE HCL 15 MG TABLET [Roxybond]319New Manufacturer
73780000410OXYCODONE HCL 30 MG TABLET [Roxybond]38New Manufacturer
73780000110OXYCODONE HCL 5 MG TABLET [Roxybond]38New Manufacturer and Strength
00069052111PAXLOVID TABLET DISK PACK 300MG/100MG 150MG/100MG UD (11/CT)40340New Manufacturer and Packaging
42794000702PROTRIPTYLINE HCL 10 MG TABLET [Vivactil]40344New Drug and Strength
42794000402PROTRIPTYLINE HCL 5 MG TABLET [Vivactil]40344New Drug and Strength
61314065101PYZCHIVA 45 MG/0.5 ML SYRINGE [Yesintek]666New Drug and Strength
61314065201PYZCHIVA 90 MG/ML SYRINGE [Yesintek]668New Drug and Strength
30698045501RALDESY 10 MG/ML SOLUTION40342New Drug
73555050000REVUFORJ 25 MG TABLET40344New Strength
68180070909RIVAROXABAN 2.5 MG TABLET [Xarelto]29195New Drug
73207030240ROMVIMZA 14 MG CAPSULE40344New Drug and Strength
73207030340ROMVIMZA 20 MG CAPSULE40344New Drug and Strength
73207030440ROMVIMZA 30 MG CAPSULE40344New Drug and Strength
51759027417SIMLANDI(CF) AI 80 MG/0.8 ML AUTOINJECTORKIT1895New Delivery Form
42658011503TICAGRELOR 90 MG TABLET [BRILINTA]31219New Drug
66993013497UMECLIDINIUM-VILANTEROL 62.5-25 BLST W/DEV [ANORO ELLIPTA]213New Drug
72252051005VALTOCO 10 MG NASAL SPRAY40344New Drug and Strength
72252051510VALTOCO 15 MG NASAL SPRAY40344New Drug and Strength
72252052010VALTOCO 20 MG NASAL SPRAY40344New Drug and Strength
72252050505VALTOCO 5 MG NASAL SPRAY40344New Drug and Strength
00078142015VANRAFIA 0.75 MG TABLET04New Drug
29033004630VENLAFAXINE HCL ER 225 MG TABLET 24H148New Manufacturer and Strength
70709012130VENXXIVA DR 100 MG TABLET011New Drug and Strength
70709012390VENXXIVA DR 300 MG TABLET011New Drug and Strength
52536048537VERAPAMIL ER PM 100 MG CAPSULE 24H PCT [Verelan PM]27227New Drug and Strength
52536048637VERAPAMIL ER PM 200 MG CAPSULE 24H PCT [Verelan PM]27227New Drug and Strength
52536048737VERAPAMIL ER PM 300 MG CAPSULE 24H PCT [Verelan PM]27227New Drug and Strength
50632001802VIMKUNYA 40 MCG/0.8 ML SYRINGE40341New Drug
83860015001VYKAT XR 150 MG TABLET ER 24H05New Drug and Strength
83860002501VYKAT XR 25 MG TABLET ER 24H05New Drug and Strength
83860007501VYKAT XR 75 MG TABLET ER 24H05New Drug and Strength
72237010601XPOVIO 40 MG ONCE WEEKLY DOSE TABLET40344New Packaging
62484001505XROMI 100 MG/ML SOLUTION011New Drug
83257002341YESINTEK 45 MG/0.5 ML SYRINGE9167New Drug and Strength
83257002411YESINTEK 45 MG/0.5 ML VIAL9167New Drug and Strength
83257002541YESINTEK 90 MG/ML SYRINGE9171New Drug and Strength
61314086602ZIEXTENZO 6 MG/0.6 ML SYRINGE748New Drug
If your brand-name drug is no longer covered by your Medicare Part D plan, you can use the 30-day notice period (if notice is provided) to:
Learn more in our article: How a mid-year formulary change can affect your Medicare Part D drug coverage.

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.